(Q46610974)

23 December 2017

title

Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea (English)

1 reference

23 December 2017

main subject

Acinetobacter baumannii

1 reference

Jeom Kyu Lee

1

1 reference

23 December 2017

Yeong Seon Lee

series ordinal

2

1 reference

23 December 2017

Yong Keun Park

series ordinal

3

1 reference

23 December 2017

Bong Su Kim

series ordinal

4

1 reference

23 December 2017

publication date

1 January 2005

1 reference

23 December 2017

Microbiology and Immunology

published in

1 reference

23 December 2017

volume

49

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

647-653

1 reference

23 December 2017

Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Comparison of ARDRA and recA-RFLP analysis for genomic species identification of Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Efflux-mediated multiresistance in Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03643.X

10.1111/J.1348-0421.2005.TB03643.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017